The store will not work correctly when cookies are disabled.
(R)-N-methyl-1-(1-phenylethyl)-N-(p-tolyl)-1H-imidazole-5-carboxamide
ID: ALA4754098
PubChem CID: 162654587
Max Phase: Preclinical
Molecular Formula: C20H21N3O
Molecular Weight: 319.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(N(C)C(=O)c2cncn2[C@H](C)c2ccccc2)cc1
Standard InChI: InChI=1S/C20H21N3O/c1-15-9-11-18(12-10-15)22(3)20(24)19-13-21-14-23(19)16(2)17-7-5-4-6-8-17/h4-14,16H,1-3H3/t16-/m1/s1
Standard InChI Key: QGSCSQHEJWUAOQ-MRXNPFEDSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.4777 -12.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8546 -13.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0157 -14.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7996 -14.4544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4223 -13.9024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2580 -13.0949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2052 -14.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3694 -14.9707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8087 -15.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2179 -16.2955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0271 -16.1296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1169 -15.3086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8335 -14.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5469 -15.3142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2636 -14.9024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9737 -15.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6857 -14.9106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6893 -14.0847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9751 -13.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2618 -14.0809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8236 -13.6179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8368 -14.0718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4054 -13.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5437 -16.1392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
9 10 2 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 1
13 22 2 0
18 23 1 0
14 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.41 | Molecular Weight (Monoisotopic): 319.1685 | AlogP: 4.08 | #Rotatable Bonds: 4 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.51 | CX LogP: 3.61 | CX LogD: 3.61 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.73 | Np Likeness Score: -1.35 |
References
1. Zhao S,Li X,Wang L,Peng W,Ye W,Li W,Wang YD,Chen WD. (2021) Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists., 32 [PMID:33440321] [10.1016/j.bmc.2020.115972] |